| |
Original Artikel |
Datum |
Titel |
Autoren Alle Autoren |
| 1 |
[GO] |
2025―Mrz―11 |
Evaluating phytochemicals as SARS-CoV-2 papain-like protease inhibitors: a docking, ADMET and molecular dynamics investigation |
Padmika Madushanka Wadanambi, Uthpali Mannapperuma, Nimanthi Jayathilaka |
| 2 |
[GO] |
2024―Nov―15 |
Identification of potential natural product inhibitors against the Mpro enzyme of Covid-19: a computational study |
Amir Zeb, Bader S. Alotaibi, Muhammad Haroon, Muhammad Sameer, Mubarak A. Alamri, Asaad Khalid, Abdul Wadood |
| 3 |
[GO] |
2024―Mrz―14 |
5-chloro-3-(2-(2,4-dinitrophenyl) hydrazono)indolin-2-one: synthesis, characterization, biochemical and computational screening against SARS-CoV-2 |
Felicite Majoumo-Mbe, Neba Abongwa Sangbong, Alain Tadjong Tcho, Cyril T. Namba-Nzanguim, Conrad V. Simoben, Donatus B. Eni, et al. (+7) Mustafa Alhaji Isa, Adi Narayana Reddy Poli, Joel Cassel, Joseph M. Salvino, Luis J. Montaner, Ian Tietjen, Fidele Ntie-Kang |
| 4 |
[GO] |
2024―Jan―17 |
Overview of diagnostic tools and nano-based therapy of SARS-CoV-2 infection |
Bedanta Bhattacharjee, Damanbhalang Rynjah, Abdul Baquee Ahmed, Arzoo Newar, Sindhuja Sengupta, Sanheeta Chakrabarty, et al. (+2) Ram Kumar Sahu, Jiyauddin Khan |
| 5 |
[GO] |
2023―Apr―13 |
Fluorine-a small magic bullet atom in the drug development: perspective to FDA approved and COVID-19 recommended drugs |
Girish Chandra, Durg Vijay Singh, Gopal Kumar Mahato, Samridhi Patel |
| 6 |
[GO] |
2023―Apr―04 |
Superior possibilities and upcoming horizons for nanoscience in COVID-19: noteworthy approach for effective diagnostics and management of SARS-CoV-2 outbreak |
Bedanta Bhattacharjee, Abu Md Ashif Ikbal, Atika Farooqui, Ram Kumar Sahu, Sakina Ruhi, Ayesha Syed, et al. (+3) Andang Miatmoko, Danish Khan, Jiyauddin Khan |
| 7 |
[GO] |
2023―Mrz―30 |
Correction to: In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19 |
Zohreh Esam, Malihe Akhavan, Maryam Lotfi, Saeed Pourmand, Ahmadreza Bekhradnia |
| 8 |
[GO] |
2022―Nov―21 |
An economical and practical procedure of favipiravir synthesis for the treatment of Covid-19 |
Hacer Karatas, Essam Hamied Ahmed Hanashalshahaby, Unal Catal, Yasar Enes Butun, Elif Kurt, Sahin Gursel, et al. (+2) Adil Kaya, Mustafa Guzel |
| 9 |
[GO] |
2022―Okt―21 |
In silico investigation of the therapeutic and prophylactic potential of medicinal substances bearing guanidine moieties against COVID-19 |
Zohreh Esam, Malihe Akhavan, Maryam Lotfi, Saeed Pourmand, Ahmadreza Bekhradnia |
| 10 |
[GO] |
2022―Okt―04 |
Potential antiviral peptides against the nucleoprotein of SARS-CoV-2 |
Iktedar Mahdi, Humyara Yeasmin, Imtiaz Hossain, Raina Masnoon Badhan, Md. Ackas Ali, Md. Abdul Kaium, et al. (+3) Rajib Islam, Md. Abu Sufian, Mohammad A. Halim |
| 11 |
[GO] |
2022―Jun―22 |
Insighting isatin derivatives as potential antiviral agents against NSP3 of COVID-19 |
Mubashar Ilyas, Shabbir Muhammad, Javed Iqbal, Saniyah Amin, Abdullah G. Al-Sehemi, H. Algarni, et al. (+3) Saleh S. Alarfaji, Mohammad Y. Alshahrani, Khurshid Ayub |
| 12 |
[GO] |
2022―Apr―03 |
In silico approach for the development of novel antiviral compounds based on SARS-COV-2 protease inhibition |
Vanja P. Ničkčović, Gordana R. Nikolić, Biserka M. Nedeljković, Nebojša Mitić, Snežana Filipović Danić, Jadranka Mitić, et al. (+3) Zoran Marčetić, Dušan Sokolović, Aleksandar M. Veselinović |
| 13 |
[GO] |
2022―Jan―27 |
Exploring the inhibitory potential of novel bioactive compounds from mangrove actinomycetes against nsp10 the major activator of SARS-CoV-2 replication |
Shabbir Muhammad, Mahnoor Qaisar, Javed Iqbal, Rasheed Ahmad Khera, Abdullah G. Al-Sehemi, Saleh S. Alarfaji, Muhammad Adnan |
| 14 |
[GO] |
2022―Jan―15 |
Modelling the DFT structural and reactivity study of feverfew and evaluation of its potential antiviral activity against COVID-19 using molecular docking and MD simulations |
Shradha Lakhera, Kamal Devlal, Arabinda Ghosh, Papia Chowdhury, Meenakshi Rana |
| 15 |
[GO] |
2021―Okt―19 |
Imidazoles and benzimidazoles as putative inhibitors of SARS-CoV-2 B.1.1.7 (Alpha) and P.1 (Gamma) variant spike glycoproteins: A computational approach |
Vidyasrilekha. Yele, Bharat Kumar Reddy. Sanapalli, Afzal Azam. Mohammed |
| 16 |
[GO] |
2021―Okt―18 |
Structure-based docking, pharmacokinetic evaluation, and molecular dynamics-guided evaluation of traditional formulation against SARS-CoV-2 spike protein receptor bind domain and ACE2 receptor complex |
B. Harish kumar, Suman Manandhar, Chetan H. Mehta, Usha Y. Nayak, K. Sreedhara Ranganath Pai |
| 17 |
[GO] |
2021―Okt―05 |
Novel Molecules derived from 3-O-(6-galloylglucoside) inhibit Main Protease of SARS-CoV 2 In Silico |
Haruna Isiyaku Umar, Adeola Ajayi, Ridwan Opeyemi Bello, Hafsat Olateju Alabere, Afees Akinbode Sanusi, Olamide Olusegun Awolaja, et al. (+2) Mohammed Mansour Alshehri, Prosper Obed Chukwuemeka |
| 18 |
[GO] |
2021―Aug―30 |
Computational insights into binding mechanism of drugs as potential inhibitors against SARS-CoV-2 targets |
Mahreen Arooj, Ihsan Shehadi, Chahlaa N. Nassab, Ahmed A. Mohamed |
| 19 |
[GO] |
2021―Aug―09 |
Metal doped fullerene complexes as promising drug delivery materials against COVID-19 |
Shamsa Bibi, Shafiq Urrehman, Laryeb Khalid, Muhammad Yaseen, Abdul Quyyam Khan, Ran Jia |
| 20 |
[GO] |
2021―Mai―08 |
An insight into the inhibitory mechanism of phytochemicals and FDA-approved drugs on the ACE2-Spike complex of SARS-CoV-2 using computational methods |
Vinod Jani, Shruti Koulgi, V. N. Mallikarjunachari Uppuladinne, Uddhavesh Sonavane, Rajendra Joshi |
